Search research articles
Contact Us
Filters
Showing results (31-40 of 830) with videos related to
Page
of 83
Sort By:
Stem Cell Investigation
|
January 13, 2017
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Hiroyuki Yamakawa, Keiichi Fukuda
Clinical Calcium
|
March 7, 2007
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Daihiko Hakuno, Keiichi Fukuda
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 25, 2009
MicroRNA is a new diagnostic and therapeutic target for cardiovascular disease and regenerative medicine
Ruri Kaneda, Keiichi Fukuda
Transplantation Reviews (Orlando, Fla.)
|
December 17, 2011
Strategies for replacing myocytes with induced pluripotent stem in clinical protocols
Fumiyuki Hattori, Keiichi Fukuda
Circulation Research
|
May 13, 2017
Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
Shugo Tohyama, Keiichi Fukuda
Journal of Molecular and Cellular Cardiology
|
February 1, 2011
Cardiovascular stem cells revisited
Manuel Mayr, Keiichi Fukuda
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 24, 2012
[Metabolic remodeling in the ischemic and non-ischemic failing heart]
Motoaki Sano, Keiichi Fukuda
Experimental & Molecular Medicine
|
February 19, 2010
Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium
Fumiyuki Hattori, Keiichi Fukuda
Expert Review of Cardiovascular Therapy
|
June 24, 2008
Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era
Shinsuke Yuasa, Keiichi Fukuda
Current Cardiology Reviews
|
November 2, 2010
Cardiac innervation and sudden cardiac death
Masaki Ieda, Keiichi Fukuda
Page
of 83
Search research articles
Search
Showing results (31-40 of 830) with videos related to
Sort By:
Page
of 83
Stem Cell Investigation
|
January 13, 2017
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Hiroyuki Yamakawa, Keiichi Fukuda
Clinical Calcium
|
March 7, 2007
[Role of anti-angiogenic factor chondromodulin-I for maintaining cardiac valvular function]
Daihiko Hakuno, Keiichi Fukuda
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 25, 2009
MicroRNA is a new diagnostic and therapeutic target for cardiovascular disease and regenerative medicine
Ruri Kaneda, Keiichi Fukuda
Transplantation Reviews (Orlando, Fla.)
|
December 17, 2011
Strategies for replacing myocytes with induced pluripotent stem in clinical protocols
Fumiyuki Hattori, Keiichi Fukuda
Circulation Research
|
May 13, 2017
Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?
Shugo Tohyama, Keiichi Fukuda
Journal of Molecular and Cellular Cardiology
|
February 1, 2011
Cardiovascular stem cells revisited
Manuel Mayr, Keiichi Fukuda
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
April 24, 2012
[Metabolic remodeling in the ischemic and non-ischemic failing heart]
Motoaki Sano, Keiichi Fukuda
Experimental & Molecular Medicine
|
February 19, 2010
Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium
Fumiyuki Hattori, Keiichi Fukuda
Expert Review of Cardiovascular Therapy
|
June 24, 2008
Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era
Shinsuke Yuasa, Keiichi Fukuda
Current Cardiology Reviews
|
November 2, 2010
Cardiac innervation and sudden cardiac death
Masaki Ieda, Keiichi Fukuda
Page
of 83